Work

Virologic and Immunologic Benefits of Initial Combination Therapy with Zidovudine and Zalcitabine or Didanosine Compared with Zidovudine Monotherapy

Year: 1996

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Journal of Infectious Diseases

DOI: 10.1093/infdis/173.6.1354

Authors: R. T. Schooley, C. Ramirez-Ronda, J. M. A. Lange, D. A. Cooper, J. Lavelle, L. Lefkowitz, M. Moore, B. A. Larder, M. S. Clair, J. Willem Mulder, R. McKinnis, K. N. Pennington, P. R. Harrigan, I. Kinghorn, H. Steel, J. F. Rooney, Wellcome Resistance Study Collaborative Group

Institution: University of Colorado Health

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2115053576

FWCI: 15.95

Cites: 22

Cited by: 92

Related to: 10